Efficacy of ibandronate for the treatment of skeletal events in patients with metastatic breast cancer.

@article{Heras2009EfficacyOI,
  title={Efficacy of ibandronate for the treatment of skeletal events in patients with metastatic breast cancer.},
  author={Panagiotis Heras and Konstantinos Kritikos and Antonios Hatzopoulos and A P Georgopoulou},
  journal={European journal of cancer care},
  year={2009},
  volume={18 6},
  pages={653-6}
}
Patients with breast carcinoma often develop bone metastases that carry a high risk of complications. A randomized, placebo-controlled trial was conducted to evaluate the efficacy and safety of ibandronate in patients with metastatic bone disease following breast cancer. The primary efficacy end point of the study was the proportion of patients who developed skeletal-related events (SREs, defined as pathologic fracture, spinal cord compression, radiation therapy to bone, change in anti… CONTINUE READING
11 Citations
21 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 21 references

Oral ibandronate

  • J. J. Body, I. J. Diel, +5 authors B. Bergstrom
  • 2004
Highly Influential
3 Excerpts

The Authors Journal compilation

  • HERAS
  • 2009

Similar Papers

Loading similar papers…